Concepedia

Tyler Robinson

TR

5

Publications

318

Citations

5

H-Index

2013

Active since

Affiliations

University of Perugia(Current)

University Health Network

University of Toronto

Hospital for Sick Children

Lunenfeld-Tanenbaum Research Institute

Tyler Robinson is an author at University of Perugia specializing in drug discovery, high-throughput screening, and tumor biology.

ORCID

Top concepts

Publications per year

2013–2023

5

Publications

5

RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation

Robert A. Jones, Tyler Robinson, Jeff C. Liu et al. · Journal of Clinical Investigation · 2016 · 145 citations · Full text

RB1 Status in Triple Negative Breast Cancer Cells Dictates Response to Radiation Treatment and Selective Therapeutic Drugs

Tyler Robinson, Jeff C. Liu, Frederick S. Vizeacoumar et al. · PLoS ONE · 2013 · 89 citations · Full text

High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: Interaction with IQ motif-containing factors

Tyler Robinson, Melody Y. Pai, Jeff Liu et al. · Cell Cycle · 2013 · 51 citations · Full text

, , +18

A CXCR4 inhibitor (balixafortide) enhances docetaxel‐mediated antitumor activity in a murine model of prostate cancer bone metastasis

Tyler Robinson, June Escara‐Wilke, Jinlu Dai et al. · The Prostate · 2023 · 20 citations · Full text

Targeted Notch1 inhibition with a Notch1 antibody, OMP‐A2G1, decreases tumor growth in two murine models of prostate cancer in association with differing patterns of DNA damage response gene expression

Aqila Ahmed, Tyler Robinson, Monica Palande et al. · Journal of Cellular Biochemistry · 2019 · 13 citations · Full text

Rows per page

1–5 of 5